Stay updated with breaking news from Benjamin Rome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
Study finds no difference in revenue between drugs for rare diseases and the general population
New rules designed to reduce Medicaid’s costs give pharma companies incentive to be less opaque.
The announcement garnered Lilly positive headlines and the appearance of being a good corporate citizen.
Humira prices were expected to drop in 2016 when AbbVie's patent expired. Instead, AbbVie tied up competitors with litigation and raised prices 60 percent.